|
1
|
Cao SM, Simons MJ and Qian CN: The
prevalence and prevention of nasopharyngeal carcinoma in China.
Chin J Cancer. 30:114–119. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee VH, Lam KO, Chang AT, Lam TC, Chiang
CL, So TH, Choi CW and Lee AW: Management of nasopharyngeal
carcinoma: Is adjuvant therapy needed? J Oncol Pract. 14:594–602.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang TT, Chen ZZ, Xie P, Zhang WJ, Du MY,
Liu YT, Zhu HY and Guo YS: Isoliquiritigenin suppresses the
proliferation and induced apoptosis via miR-32/LATS2/Wnt in
nasopharyngeal carcinoma. Eur J Pharmacol. 856:1723522019.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yi SJ, Liu P, Chen BL, Ou-Yang L, Xiong WM
and Su JP: Circulating miR-31-5p may be a potential diagnostic
biomarker in nasopharyngeal carcinoma. Neoplasma. 66:825–829. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Genova P, Brunetti F, Bequignon E, Landi
F, Lizzi V, Esposito F, Charpy C, Calderaro J, Azoulay D and
deAngelis N: Solitary splenic metastasis from nasopharyngeal
carcinoma: A case report and systematic review of the literature.
World J Surg Oncol. 14:1842016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Venkatadri R, Muni T, Iyer AK, Yakisich JS
and Azad N: Role of apoptosis-related miRNAs in resveratrol-induced
breast cancer cell death. Cell Death Dis. 7:e21042016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dou L, Han K, Xiao M and Lv F: miR-223-5p
suppresses tumor growth and metastasis in non-small cell lung
cancer by targeting E2F8. Oncol Res. 27:261–268. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wei Y, Peng J, He S, Huang H, Lin L, Zhu
Q, Ye L, Li T, Zhang X, Gao Y and Zheng X: miR-223-5p targeting ERG
inhibits prostate cancer cell proliferation and migration. J
Cancer. 11:4453–4463. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sugawara S, Yamada Y, Arai T, Okato A,
Idichi T, Kato M, Koshizuka K, Ichikawa T and Seki N: Dual strands
of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer
cell aggressiveness: Targeted genes are involved in bladder cancer
pathogenesis. J Hum Genet. 63:657–668. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ferguson FM, Nabet B, Raghavan S, Liu Y,
Leggett AL, Kuljanin M, Kalekar RL, Yang A, He S, Wang J, et al:
Discovery of a selective inhibitor of doublecortin like kinase 1.
Nat Chem Biol. 16:635–643. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sureban SM, May R, Qu D, Weygant N,
Chandrakesan P, Ali N, Lightfoot SA, Pantazis P, Rao CV, Postier RG
and Houchen CW: DCLK1 regulates pluripotency and angiogenic factors
via microRNA-dependent mechanisms in pancreatic cancer. PLoS One.
8:e739402013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shan C, Fei F, Li F, Zhuang B, Zheng Y,
Wan Y and Chen J: miR-448 is a novel prognostic factor of lung
squamous cell carcinoma and regulates cells growth and metastasis
by targeting DCLK1. Biomed Pharmacother. 89:1227–1234. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liang H, Yu T, Han Y, Jiang H, Wang C, You
T, Zhao X, Shan H, Yang R, Yang L, et al: LncRNA PTAR promotes EMT
and invasion-metastasis in serous ovarian cancer by competitively
binding miR-101-3p to regulate ZEB1 expression. Mol Cancer.
17:1192018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chandrakesan P, Yao J, Qu D, May R,
Weygant N, Ge Y, Ali N, Sureban SM, Gude M, Vega K, et al: Dclk1, a
tumor stem cell marker, regulates pro-survival signaling and
self-renewal of intestinal tumor cells. Mol Cancer. 16:302017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang J, Wang S, Zhou J and Qian Q:
miR-424-5p regulates cell proliferation, migration and invasion by
targeting doublecortin-like kinase 1 in basal-like breast cancer.
Biomed Pharmacother. 102:147–152. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mohammadi Y, Tavangar SM, Saidijam M,
Amini R, Etemadi K, Karimi Dermani F and Najafi R: DCLK1 plays an
important role in colorectal cancer tumorgenesis through the
regulation of miR-200c. Biomed Pharmacother. 103:301–307. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang Z, Yuan XG, Chen J, Luo SW, Luo ZJ
and Lu NH: Reduced expression of PTEN and increased PTEN
phosphorylation at residue Ser380 in gastric cancer tissues: A
novel mechanism of PTEN inactivation. Clin Res Hepatol
Gastroenterol. 37:72–79. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu H, Wen T, Zhou Y, Fan X, Du T, Gao T,
Li L, Liu J, Yang L, Yao J, et al: DCLK1 plays a
metastatic-promoting role in human breast cancer cells. Biomed Res
Int. 2019:10619792019.PubMed/NCBI
|
|
21
|
Liu W, Wang S, Sun Q, Yang Z, Liu M and
Tang H: DCLK1 promotes epithelial-mesenchymal transition via the
PI3K/Akt/NF-κB pathway in colorectal cancer. Int J Cancer.
142:2068–2079. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu ZQ, He WF, Wu YJ, Zhao SL, Wang L,
Ouyang YY and Tang SY: LncRNA SNHG1 promotes EMT process in gastric
cancer cells through regulation of the miR-15b/DCLK1/Notch1 axis.
BMC Gastroenterol. 20:1562020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen YP, Chan ATC, Le QT, Blanchard P, Sun
Y and Ma J: Nasopharyngeal carcinoma. Lancet. 394:64–80. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Deng M, Tang H, Zhou Y, Zhou M, Xiong W,
Zheng Y, Ye Q, Zeng X, Liao Q, Guo X, et al: miR-216b suppresses
tumor growth and invasion by targeting KRAS in nasopharyngeal
carcinoma. J Cell Sci. 124:2997–3005. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lu J, He ML, Wang L, Chen Y, Liu X, Dong
Q, Chen YC, Peng Y, Yao KT, Kung HF and Li XP: MiR-26a inhibits
cell growth and tumorigenesis of nasopharyngeal carcinoma through
repression of EZH2. Cancer Res. 71:225–233. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li Y, He Q, Wen X, Hong X, Yang X, Tang X,
Zhang P, Lei Y, Sun Y, Zhang J, et al: EZH2-DNMT1-mediated
epigenetic silencing of miR-142-3p promotes metastasis through
targeting ZEB2 in nasopharyngeal carcinoma. Cell Death Differ.
26:1089–1106. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wong QW, Lung RW, Law PT, Lai PB, Chan KY,
To KF and Wong N: MicroRNA-223 is commonly repressed in
hepatocellular carcinoma and potentiates expression of Stathmin1.
Gastroenterology. 135:257–269. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kurozumi A, Goto Y, Matsushita R, Fukumoto
I, Kato M, Nishikawa R, Sakamoto S, Enokida H, Nakagawa M, Ichikawa
T and Seki N: Tumor-suppressive microRNA-223 inhibits cancer cell
migration and invasion by targeting ITGA3/ITGB1 signaling in
prostate cancer. Cancer Sci. 107:84–94. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang W, Lan X, Li D, Li T and Lu S:
MiR-223 targeting MAFB suppresses proliferation and migration of
nasopharyngeal carcinoma cells. BMC Cancer. 15:4612015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang W, Zhang H, Wang L, Zhang S and Tang
M: miR-613 inhibits the growth and invasiveness of human
hepatocellular carcinoma via targeting DCLK1. Biochem Biophys Res
Commun. 473:987–992. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sakaguchi M, Hisamori S, Oshima N, Sato F,
Shimono Y and Sakai Y: miR-137 regulates the tumorigenicity of
colon cancer stem cells through the inhibition of DCLK1. Mol Cancer
Res. 14:354–362. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wan MF, Yang N, Qu NY, Pan YY, Shan YQ and
Li P: MiR-424 suppressed viability and invasion by targeting to the
DCLK1 in neuroblastoma. Eur Rev Med Pharmacol Sci. 24:5526–5533.
2020.PubMed/NCBI
|
|
33
|
Ito H, Tanaka S, Akiyama Y, Shimada S,
Adikrisna R, Matsumura S, Aihara A, Mitsunori Y, Ban D, Ochiai T,
et al: Dominant expression of DCLK1 in human pancreatic cancer stem
cells accelerates tumor invasion and metastasis. PLoS One.
11:e01465642016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang YL, Li Y, Ma YG and Wu WY: DCLK1
promotes malignant progression of breast cancer by regulating
Wnt/β-catenin signaling pathway. Eur Rev Med Pharmacol Sci.
23:9489–9498. 2019.PubMed/NCBI
|
|
35
|
Yuan X, Wu H, Xu H, Xiong H, Chu Q, Yu S,
Wu GS and Wu K: Notch signaling: An emerging therapeutic target for
cancer treatment. Cancer Lett. 369:20–27. 2015. View Article : Google Scholar : PubMed/NCBI
|
